2009

December 07, 2009 Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain

December 03, 2009 Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain

November 19, 2009 Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution

November 12, 2009 Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever

October 22, 2009 Nutra Pharma Announces Publication of Research Report by Cohen Independent Research Group

October 14, 2009 Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain

October 07, 2009 Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain

October 05, 2009 Online Financial Publication, CEO-CFO, Interviews Nutra Pharma Chairman and CEO

October 02, 2009 Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain

September 24, 2009 The Wall Street Transcript Interviews Nutra Pharma Chairman and CEO

September 21, 2009 Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever

August 31, 2009 Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference

August 26, 2009 Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain

August 24, 2009 Nutra Pharma Completes FDA Submission for Cobroxin - a Drug for the Treatment of Stage 2 (Moderate to Severe) Chronic Pain

August 20, 2009 Nutra Pharma Announces Launch of Cobroxin, an Over-The-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain

August 13, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for the Oral Delivery of Cobra Venom for the Treatment of Pain

June 08, 2009 Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain

March 26, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms

March 09, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification

February 17, 2009 Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study

February 09, 2009 Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for Novel Treatment of Arthritis Using RPI-78

2008

December 08, 2008 Nutra Pharma Receives Clinical Drug Supply Contract

November 17, 2008 Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients

August 14, 2008 Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)

August 06, 2008 Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)

August 01, 2008 August 2008 Shareholder Letter from Chairman and CEO Rik J. Deitsch

July 29, 2008 Nutra Pharma Announces Completion of Clinical Study in Adrenomyeloneuropathy (AMN)

May 19, 2008 Nutra Pharma Subsidiary, ReceptoPharm, Receives Approval to Begin Clinical Trials for the Treatment of Feline Leukemia Virus (FeLV)

April 14, 2008 Nutra Pharma Acquires Remaining Interest in Biopharmaceutical Drug Discovery Company - ReceptoPharm, Inc.

February 28, 2008 Nutra Pharma Announces Launch of Corporate Blog

February 25, 2008 Designer Diagnostics Begins Marketing First Ever Environmental Test Kit for the Detection of Nontuberculous Mycobacteria

2007

December 27, 2007 Nutra Pharma Expands Licensing Agreement to Include Environmental Testing for NonTuberculous Mycobacterium

December 17, 2007 Nutra Pharma Announces Successful Completion of 6-Month Patient Crossover in AMN Clinical Trial

November 28, 2007 Nutra Pharma Posts ReceptoPharm Peer-Reviewed Article to Its Website

November 19, 2007 Nutra Pharma Announces Publication of Test Kit Technology in the International Journal of TB and Lung Diseases

November 08, 2007 Nutra Pharma Announces Designer Diagnostics Test Kit Technology to Be Presented at International Lung Health Conference

August 13, 2007 Shareholder Letter from Chairman and CEO Rik J. Deitsch

August 08, 2007 Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study

July 10, 2007 Nutra Pharma Announces Successful Enrollment in ReceptoPharm Adrenomyeloneuropathy (AMN) Study

May 31, 2007 Nutra Pharma Announces Breakthrough with Rapid Tuberculosis Test Kit Technology

May 02, 2007 Nutra Pharma Announces Designer Diagnostics' Clinical Trials to Be Conducted at National Jewish Medical and Research Center

April 17, 2007 Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China

April 11, 2007 Nutra Pharma Announces ReceptoPharm Patent for a Method of Treating Multiple Sclerosis

March 27, 2007 Nutra Pharma Completes First Royalty Payment to NanoLogix for Test Kit Technology

March 26, 2007 Nutra Pharma Sponsors Educational Website about Tuberculosis (TB) in Conjunction with World TB Day

March 22, 2007 Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis

March 07, 2007 Nutra Pharma Announces ReceptoPharm's Joint Venture with Chinese Biotechnology Company

March 01, 2007 Designer Diagnostics Engages U.S. Commercial Service for International Growth

February 28, 2007 Nutra Pharma Announces Partnership with World Aids Campaign

February 22, 2007 The Wall Street Transcript Interviews Nutra Pharma Chairman and CEO

February 14, 2007 Nutra Pharma Announces Shareholder Conference Call Scheduled for Wednesday, February 14, 2007

February 12, 2007 Nutra Pharma Chairman and CEO Outlines Business Strategy and Goals on CEOCast.com Interview

February 09, 2007 Nutra Pharma Announces Shareholder Conference Call to Discuss Recent News and Progress

February 08, 2007 National Television Series, Business & Beyond, to Feature Nutra Pharma on CNBC

February 07, 2007 ReceptoPharm Expands Antiviral Clinical Research to South America

January 29, 2007 ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy

January 22, 2007 Shareholder Letter from Chairman and CEO Rik J. Deitsch

January 18, 2007 Designer Diagnostics Announces Positive Results from In-Vitro Analysis

January 16, 2007 Nutra Pharma Sponsors Educational Website for Adrenomyeloneuropathy (AMN)

January 11, 2007 Nutra Pharma Announces Breakthrough Research in the Treatment of Viral Infections

January 05, 2007 Nationally Distributed Magazine Publishes Article by Nutra Pharma Chairman and CEO Rik J Deitsch

2006

November 28, 2006 Nutra Pharma Announces ReceptoPharm to Present at the International Conference on Neurotoxins

November 21, 2006 Shareholder Letter from Chairman and CEO Rik J. Deitsch

November 03, 2006 Nutra Pharma Featured on Fox 2 News in St. Louis

October 31, 2006 Nutra Pharma Adopts Famous 2-Headed Snake of St. Louis World Aquarium

October 05, 2006 Nutra Pharma Announces Final Approval to Begin Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy

September 21, 2006 Nutra Pharma Announces ReceptoPharm to Be a Featured Speaker at the 11th Annual Immunobiology Symposium

August 31, 2006 Shareholder Letter from Chairman and CEO Rik J. Deitsch

August 29, 2006 Nutra Pharma Announces Former GlaxoSmithKline Global Clinical Development Director Joins ReceptoPharm Scientific Advisory Board

August 21, 2006 Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Pain Study

July 14, 2006 Business 2.0 Publishes Article about Nutra Pharma Corporation

July 13, 2006 WallSt.Net Publishes Interview with Nutra Pharma CEO Rik J. Deitsch

June 19, 2006 ReceptoPharm Signs Letter of Intent to Be Acquired by Nutra Pharma Corporation

May 31, 2006 Shareholder Letter from Chairman and CEO Rik J. Deitsch

May 09, 2006 Nutra Pharma Announces Approval to Start Late Phase II Human Trials in England

May 04, 2006 Nutra Pharma Sponsors Educational Website for Nontuberculous Mycobacterium (NTM)

May 03, 2006 The JALMA Institute Signs Purchase Agreement for Nutra Pharma's NTM Test Kits

April 19, 2006 Health on the Net Foundation Accredits Nutra Pharma Website

April 11, 2006 Nutra Pharma CEO Outlines Corporate Strategy on MacReport.Net

April 05, 2006 Nutra Pharma Launches Diagnostic Test Kits for the Rapid Identification of Nontuberculous Mycobacterium

March 31, 2006 Nutra Pharma Announces Svizera Labs to Supply Designer Diagnostics' Test Kits to the World Health Organization

March 21, 2006 Nutra Pharma Engages HealthForce LLC for Sales, Marketing and Distribution of Designer Diagnostics' Test Kits

March 16, 2006 Nutra Pharma Announces Full-Day Workshop in India to Introduce Designer Diagnostics' Test Kits

February 28, 2006 The Wall Street Transcript Publishes Interview With Nutra Pharma CEO Rik J. Deitsch

February 22, 2006 Nutra Pharma Accepted Into the Stop TB Partnership

February 09, 2006 Nutra Pharma Reports Preclinical Results of RPI-78M in Multiple Sclerosis to Be Presented at Scientific Meeting

February 06, 2006 Nutra Pharma Names Microbiologist and Former Infectech Executive to Head the Advisory Board of Designer Diagnostics

January 26, 2006 Nutra Pharma Incorporates Designer Diagnostics, Inc. -- a New Subsidiary to Market Medical Test Kits

January 25, 2006 Nutra Pharma Acquires Patents and Licenses for Medical Test Kits

2005

December 27, 2005 Nutra Pharma Engages Isserman Consulting for Public Awareness and Investor Relations

December 20, 2005 Nutra Pharma Reports Final Results for ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model

December 19, 2005 Nutra Pharma Reports Discovery of New Gene Involved in Multiple Sclerosis

November 23, 2005 Nutra Pharma Penetrates the China Market

October 12, 2005 Nutra Pharma Announces ReceptoPharm Facilities Have Been GMP-Certified for Drug Production

September 16, 2005 Nutra Pharma Announces RPI-MN Shows Positive Effects against Drug-Resistant Strains of HIV

August 18, 2005 Nutra Pharma Announces $9.6 Million Financing Agreement

March 15, 2005 Interview with Nutra Pharma CEO Available Online

February 24, 2005 Wall Street Reporter Interviews Nutra Pharma's CEO

February 08, 2005 Nutra Pharma Reports that ReceptoPharm will be Presenting at The Adrenomyeloneuropathy (AMN) Forum in London

February 08, 2005 Business & Beyond to Feature Nutra Pharma Corporation

February 02, 2005 Nutra Pharma Corporation Will be Presenting at The Wall Street Analyst Forum

January 24, 2005 Nutra Pharma Names Dr. Tanvir Khandaker to Board of Directors

2004

December 08, 2004 Nutra Pharma Engages Research Group to Validate Portage BioMed Technology

December 07, 2004 Nutra Pharma Corrects November 9, 2004 Press Release Stating "Nutra Pharma Signs Agreement to Acquire Portage BioMed"

November 19, 2004 Nutra Pharma Reports Infectech Engages Lake Erie Research Institute for FDA Submissions

November 15, 2004 Nutra Pharma Reports Preliminary Results of ReceptoPharm's Multiple Sclerosis Drug in Microarray Studies

November 15, 2004 Nutra Pharma Names Dr. Stewart Lonky to Board of Directors

November 09, 2004 Nutra Pharma Signs Agreement to Acquire Portage Biomed

November 03, 2004 Nutra Pharma Reports Further Validation of Infectech's Identikit Technology

October 05, 2004 Nutra Pharma Announces Board Changes and Loan Settlement

October 04, 2004 Nutra Pharma Reports Positive Results For ReceptoPharm's RPI-78M in Multiple Sclerosis Animal Model

September 29, 2004 Nutra Pharma Engages Equitilink LLC for Investor Relations

September 07, 2004 Nutra Pharma Reports Third Party Validation of Infectech's Identikit Technology

September 01, 2004 Nutra Pharma Reports ReceptoPharm Assays Prove That Experimental HIV Drug May Be Widely Available after Approval

August 30, 2004 Ohio State University Researcher Receives Competitive Grant Utilizing Infectech, Inc. Technology

August 02, 2004 Nutra Pharma Engages Research Group to Study RPI-78M in Multiple Sclerosis Assays

May 18, 2004 Nutra Pharma Reports ReceptoPharm's Completion of a Critical First Step in Their Lead Drug's Production

May 05, 2004 Nutra Pharma Reports Successful Completion of ReceptoPharm's HIV In-Vitro Studies at Two Leading Universities

April 28, 2004 Nutra Pharma Retains Rubenstein Investor Relations, Inc. as Investor Relations Consultants

2003

October 20, 2003 Nutra Pharma Corporation Announces Acquisition of Controlling Interest in Infectech, Inc.

October 06, 2003 Nutra Pharma Corporation Receives Licenses to Intellectual Property in Settlement with Bio Therapeutics Inc.

September 22, 2003 Nutra Pharma Corporation Signs Definitive Agreement to Acquire Infectech Corporation

September 08, 2003 Nutra Pharma Corp. to Acquire Infectech Inc.

February 24, 2003 Infectech, Inc. Awarded Attorney Fees and Costs After Federal Court Dismissed Involuntary Petition